Soft2Bet ties AML activity monitoring to risk flags and review, turning raw signals into governed, verifiable iGaming ...

Risk monitoring is the ongoing process of identifying, understanding, assessing, monitoring, managing, and mitigating risks that could adversely affect an organization's operations, value, assets and ...

The U.S. Food and Drug Administration (FDA) recently finalized its guidance, “A Risk-Based Approach to Monitoring of Clinical Investigations” (the “2023 RBM Guidance”) which follows up on the Agency’s ...

In this free webinar, gain insight into the key elements to reduce risk for clinical trials. Attendees will learn how Independent Review and Data Analytics in eCOA strengthen endpoint integrity and ...

Organizations are integrating previously disparate services to better align their offerings with the shift from fee-for-service to risk-based care through visionary, member-centric solutions. For ...

The US Food and Drug Administration (FDA) on Tuesday issued final guidance meant to assist drug and medical device makers in developing risk-based monitoring strategies for clinical investigations ...

Dublin, Aug. 23, 2023 (GLOBE NEWSWIRE) -- The "Global Risk-based Monitoring Software Market by Function, Delivery Mode, End-User - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High ...

Pfizer and Bristol-Myers Squibb (BMS) recently raised questions with and sought further clarity from the US Food and Drug Administration (FDA) on a draft guidance related to the risk-based monitoring ...

Clinical trials can often take between six and seven years to complete, but that timeline isn’t always practical for the problems pharmaceutical companies are trying to solve. Additionally, six years ...

Regulators require that financial services companies take a risk-based approach (RBA) to maintain compliance, which can seem like a heavy burden on businesses in terms of costs, workforce and ...